Vanguard Group Inc Biora Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 10, 2023	BUY	$0.13 - $12.03 $340 - $31,542	2,622 Added 0.04%	5,900,329 $767,000
Q3 2022 Nov 14, 2022	BUY	$0.53 - $13.3 $104,197 - $2.61 Million	196,599 Added 3.45%	5,897,707 $2.86 Million
Q2 2022 Aug 12, 2022	BUY	$0.56 - $1.22 $305,318 - $665,158	545,212 Added 10.57%	5,701,108 $3.99 Million
Q1 2022 May 13, 2022	BUY	$1.11 - $2.25 $407,899 - $826,823	367,477 Added 7.67%	5,155,896 $5.98 Million
Q4 2021 Feb 14, 2022	BUY	$1.35 - $4.89 $5.21 Million - $18.9 Million	3,862,353 Added 417.07%	4,788,419 $10 Million
Q3 2021 Nov 12, 2021	BUY	$0.67 - $3.41 $10,840 - $55,173	16,180 Added 1.78%	926,066 $1.41 Million
Q2 2021 Aug 13, 2021	BUY	$2.11 - $4.93 $1.92 Million - $4.49 Million	909,886 New	909,886 $3.25 Million

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $312M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.